T he excess incidence of vascular disease in subjects with the cardiovascular risk factor cluster [1] [2] [3] is only partially explained by elevations of blood pressure, lipids, and glucose. Insulin resistance may contribute independently to cardiovascular disease in patients with the risk factor cluster. 1 However, the mechanisms by which insulin resistance, apart from the traditional risk factors noted, leads to cardiovascular disease remain poorly defined. One possible contributor may be the defect in the capacity of insulin to suppress plasma concentrations and turnover of nonesterified fatty acids in patients with risk factor clustering. [4] [5] [6] We observed that oleic acid was the most abundant fatty acid in plasma and that obese hypertensive patients had higher fasting plasma oleic acid concentrations than lean normotensive subjects. 7 Cis-Unsaturated fatty acids, eg, oleic acid (18:1[cis]), can activate PKC. 8, 9 Activation of PKC has been implicated as a key signaling event in cell growth and proliferation in response to several mitogens. 10, 11 We performed experiments that demonstrated that oleic acid induced a PKC-dependent mitogenic response in rat aortic VSMCs. 12 Neither stearic (18:0) nor elaidic (18:1[trans] ) acids, which are weak activators of PKC, 8 induced a mitogenic response.
Subjects with risk factor clustering also have a more active renin-angiotensin system. 13, 14 Ang II enhances the response to several mitogens. 15 This raises the possibility that the increased oleic acid concentrations and the enhanced activity of the renin-angiotensin axis may interact to accelerate vascular changes among high-risk subjects such as obese hypertensives. Consequently, we examined the separate and combined effects of oleic acid and Ang II on thymidine uptake and cell number in rat aortic VSMCs.
Because the signal transduction pathways by which growth factors interact could have important therapeutic implications, we attempted to define early signaling events in the mitogenic response to the oleic acid-Ang II combination. Both oleic acid and Ang II activate PKC 8, 9, 12, 15, 16 and, in turn, ERKs. ERK activation is a common point in the signaling pathway for cell growth and/or differentiation in response to several different mitogens. [17] [18] [19] We examined whether the mitogenic effects of the oleic acid-Ang II combination were dependent on activation of PKC and ERK. Furthermore, given that Ang II may promote growth via AT 1 receptors and inhibit growth via AT 2 receptors, 20 the effects of selective blockers on the mitogenic response to oleic acid and Ang II were assessed.
Methods

Materials
Individual fatty acids were purchased from Sigma Chemical Co, and sodium salts were prepared as previously described. 12 Losartan was obtained from Dupont-Merck Pharmaceutical Co. PD 123319 and PD 98059 were purchased from RBI. Cell culture media were obtained from GIBCO BRL. Fatty acid-free albumin was purchased from ICN Biomedicals Inc. [ 3 H]Thymidine (6.7 Ci/mmol, 37.0 MBq) and ␥-P 32 -ATP (3000 Ci/mmol, 37 MBq) were purchased from Dupont-NEN.
Cell Culture
Rat aortic VSMCs were cultured by procedures modified from Chamley-Campbell et al 21 
Effects of Oleic Acid and Ang II on VSMC Number
In separate experiments, rat aortic VSMCs were seeded at 10 000 cells per well, grown to subconfluence, and growth-arrested by serum deprivation. These cells were incubated with oleic acid and/or Ang II, with or without 4 mol/L bisindolylmaleimide I, for 6 days with a change of media after 72 hours. Elaidic and stearic acids were used to control for potential nonspecific effects of oleic acid on cell growth. 12 Cells were resuspended with 0.3 mL trypsin/EDTA (0.05%/0.5 mmol/L), and cell number was determined using a hemocytometer.
ERK Activity Assay
Confluent VSMCs in 100-mm Petri dishes were incubated in 0.1% FBS DMEM for 48 hours. The monolayer was exposed to oleic acid, Ang II, or 10% FBS in serum-free DMEM for 10 minutes under 5% CO 2 at 37°C. The incubation was stopped by adding ice-cold PBS. Cells were scraped into PBS and pelleted by centrifugation for 20 seconds at 2000g. The pellet was suspended in cold lysis buffer. 12 The suspended pellet was sonicated for 5 seconds and centrifuged at 100 000g at 4°C. The supernatant was used as the enzyme preparation for assay of activated MAP kinase. ERK activity in cell lysates was assessed using 32 P phosphorylation of myelin basic protein. 17 ERK activity was corrected for protein and expressed as a percentage of the activity in untreated cells. Immunoblots using anti-ACTIVE MAP kinase pAb 26 -28 and anti-ERK mAb were performed to corroborate findings from the ERK activity assay. Proteins in whole cell extracts from cells treated with/without PD98059 or antisense ODNs were resolved by SDSpolyacrylamide gel electrophoresis.
12
Effects of Oleic Acid on Activation of JNK and p38
Quiescent VSMCs were treated with 50 mol/L oleic acid and/or Ang II and serum for 30 minutes or UV irradiation. For the UV experiments, cells were washed with ice-cold PBS and irradiated (254 nmol/L, UV-C) for 40 seconds. Media were added immediately after the irradiation, and the cells were harvested after 30 minutes. Proteins in whole cell extracts were resolved by SDS-polyacrylamide gel electrophoresis, electrophoretically transferred to polyvinylidene membranes, and then immunoblotted with anti-phosphospecific p38, anti-p38, anti-phospho-specific SAPK/JNK (New England Biolab, Inc), and anti-SAPK/JNK antibodies 29 (generated and provided by S.A.R.).
Statistical Analysis
Data are presented as meanϮSEM. Data were analyzed with SPSS 6.0 (SPSS Inc). One-way ANOVA followed by Duncan's multiple range test was used to compare the cell number and ERK activity 
Results
Effects of Oleic Acid and Ang II Alone and Together on [ 3 H]Thymidine Incorporation in VSMCs
Ang II from 10 Ϫ10 mol/L to 10 Ϫ8 mol/L increased thymidine incorporation from 111% to 121% of control (PϭNS). Oleic acid (50 mol/L) increased thymidine incorporation to 150% of control (PϽ.05). When 50 mol/L oleic acid was added to the media 5 minutes before Ang II, the combination of oleic acid with 10 Ϫ10 mol/L to 10 Ϫ8 mol/L Ang II synergistically enhanced thymidine incorporation from 206% to 225% of control. The synergistic interaction between oleic acid and Ang II was abolished by PKC inhibition with 4 mol/L bisindolylmaleimide I or by PKC depletion with PMA ( Fig  1) . When Ang II was added 5 minutes before oleic acid, the synergistic effect between oleic acid and Ang II on thymidine uptake was observed at 10 Ϫ11 mol/L Ang II (Fig 1) . When the sequence was reversed, 10 Ϫ11 mol/L Ang II did not synergistically enhance the response to oleic acid. The order of addition did not affect thymidine incorporation at Ang II concentrations of 10 Ϫ10 mol/L and greater.
Effect of Oleic Acid and Ang II Alone and Together on VSMC Number
After 48 hours of growth arrest with 0.1% FBS DMEM, there were 3.51Ϯ0.33ϫ10 4 cells per well (nϭ6). Under basal conditions (ie, a 6-day incubation with 0.1% FBS DMEM and 100 mol/L fatty acid-free albumin), there were 5.79Ϯ0.24ϫ10 4 
cells per well (nϭ6). Addition of 10
Ϫ10
mol/L to 10 Ϫ8 mol/L Ang II for 6 days did not increase cell number compared with the control condition (Table) . Addition of 50 mol/L oleic acid increased cell number to 155% of control, while the combination of oleic acid and Ang II from 10 Ϫ10 mol/L to 10 Ϫ8 mol/L increased cell number to 188% to 214% of control (PϽ.05) compared with oleic acid alone. In contrast to oleic acid, the same concentrations of stearic acid and elaidic acid did not increase VSMC number after 6 days (102% and 114% of control, respectively).
Effect of AT 1 and AT 2 Receptor Antagonists on Thymidine Incorporation in Response to the Oleic Acid-Ang II Combination
Oleic acid (50 mol/L) increased thymidine incorporation to 147% of control (Fig 2) . The combination of 50 mol/L oleic acid and 10 Ϫ8 mol/L Ang II induced a more marked increase to 219% of control. When cells were pretreated with 10 Ϫ5 mol/L losartan, an AT 1 receptor antagonist, values for thymidine incorporation in response to the combination of oleic acid and Ang II were not different from those for oleic acid alone. In contrast, blocking AT 2 receptors with 10 Ϫ5 mol/L PD 123319 did not prevent the synergistic interaction between oleic acid and Ang II on thymidine incorporation.
Neither 10
Ϫ5 mol/L losartan nor 10 Ϫ5 mol/L PD 123319 altered basal thymidine incorporation or the response to oleic acid (not shown).
Effect of ERK Kinase (MEK) Inhibition on ERK Activity and Thymidine Incorporation in Response to Oleic Acid and Ang II
When VSMCs were preincubated for 1 hour with 20 mol/L PD 98059, a specific MEK inhibitor, basal ERK activity was unchanged. However, stimulation of ERK activity in response to oleic acid, Ang II, and serum was reduced by Ϸ75% to 95% by PD 98059 (Fig 3A) . The findings with the ERK activity assay using myelin basic protein as the substrate were confirmed in experiments using an antibody specific for active MAP kinase and ERKs (Fig 3A) . Although active ERK-1 (Ϸ44 kD) was visible only after a longer exposure time than for active ERK-2 (Ϸ42 kD), the patterns of immunoreactivity for these two active ERK isoforms in response to oleic acid and Ang II were similar (not shown).
Control experiments using anti-ERK confirmed that equal amounts of total ERK protein were present in each of the conditions. PD 98059 reduced basal thymidine incorporation by Ϸ50% and abolished the rise of thymidine incorporation in response to 50 mol/L oleic acid and 10 Ϫ8 mol/L Ang II both singly and combined (Fig 3B) . In contrast, 20 mol/L PD 98059 did not significantly blunt thymidine incorporation in response to serum.
Effect of Antisense ODN on [ 3 H]Thymidine Incorporation in Response to Oleic Acid
Antisense experiments were performed using a 17-mer ODN targeting a consensus sequence at the initiation site for ERK-1 and ERK-2 mRNA. [23] [24] [25] Immunoblotting demonstrated that the antisense ODNs induced a concentrationdependent decrease in ERK protein 48 hours after liposomal transfection (Fig 4A) . Lipofectin alone and together with sense and scrambled ODNs did not affect ERK protein.
Antisense did not affect the expression of PKC ␣, JNK, and p38 (867Ϯ76, 344Ϯ32, and 1024Ϯ223 arbitrary units for antisense ODN-treated cells versus 913Ϯ121, 359Ϯ64, and 996Ϯ89 arbitrary units for cells treated with lipofectin, respectively). Immunoblots for phospho-MAP kinase ( Fig  4B) also showed that treatment with antisense ODNs significantly inhibited activation of the p42 and p44 MAP kinase isoforms in response to 100 mol/L oleic acid in a dosedependent manner. Microscopic observation revealed a normal morphology and viability in antisense ODN-treated cells. Antisense ODNs reduced basal thymidine incorporation Ϸ35% and prevented a significant rise of thymidine incorporation in response to 50 mol/L oleic acid and Ang II 10 Ϫ8 mol/L alone and together (Fig 5) . Antisense ODNs reduced but did not eliminate the significant increase of thymidine incorporation in response to serum. Sense ODNs did not affect thymidine incorporation in response to oleic acid or serum.
Effect of Oleic Acid on Activation of p38 and JNK
As shown in Fig 6 , serum induced activating phosphorylations of both p38 and JNK within 30 minutes. UV irradiation activated JNK only, whereas oleic acid and Ang II alone or together failed to activate either of these kinases.
Discussion
The principal finding of this study is that oleic acid and Ang II induce a synergistic mitogenic effect in rat aortic VSMCs (Fig 1, Table 1 ). While Ang II alone did not significantly increase either thymidine incorporation or cell number, it approximately doubled the increase of thymidine incorporation and cell number in response to oleic acid. Subjects with the cardiovascular risk factor cluster have an increase of plasma nonesterified fatty acids [4] [5] [6] and a more active reninangiotensin system. 13, 14 The data raise the possibility that oleic acid and Ang II combine to accelerate vascular remodeling among high-risk subjects such as obese hypertensive patients.
The potential relevance of the synergistic mitogenic interaction between oleic acid and Ang II and vascular disease among insulin-resistant subjects with the risk factor cluster is heightened by two points. First, the synergistic interaction occurs at physiological concentrations of these two growth factors. 7, 30 Although the 50-mol/L concentration of oleic acid is significantly lower than mean plasma values measured in obese hypertensive patients (172Ϯ11 mol/L), 7 nonesterified fatty acids in the extracellular fluid are predominantly bound to albumin. Albu- OA indicates oleic acid. VSMCs were seeded at 10 000 cells per well, grown to subconfluence, growth-arrested by serum deprivation, and treated with different concentrations of OA and Ang II for 6 days. Please note data discussed in "Results" indicating that cell number increased under control conditions over 6 days. Cells were then resuspended with 0.5 mL trypsin/EDTA (0.05%/ 0.5 mmol/L), and cell number was determined using a hemocytometer. Values are meanϮSEM from three independent experiments performed in duplicate.
Effects of Oleic Acid and Ang II Alone and Together for 6 Days Each on VSMC Number
*PϽ.05 compared with control at 6 days; †PϽ.05 compared with 50 mol/L OA. Second, when Ang II was added to the media before oleic acid, Ang II concentrations at the very low end of the physiological range (10 Ϫ11 mol/L) 31 augmented thymidine incorporation in combination with oleic acid. If very low concentrations of Ang II elicit most of the synergistic mitogenic effect, then the higher Ang II in subjects with risk factor clustering 13, 14 would have less impact. However, some fatty acids, including oleic acid, decrease affinity of Ang II for its receptor. 22 When oleic acid was added to the media before Ang II, a synergistic mitogenic effect was seen at 10 Ϫ10 mol/L Ang II and greater but not at 10 Ϫ11 mol/L (Fig 1) . The greater activity of the renin-angiotensin system in patients with risk factor clustering 13,14 may be essential in eliciting a synergistic mitogenic effect on VSMCs in the presence of physiological concentrations of nonesterified fatty acids. Ϫ8 mol/L Ang II alone or together and 10% FBS were added to rat aortic VSMCs with/ without 1-hour preincubation in 20 mol/L PD 98059 for 10 minutes. Cells were harvested and cytosolic extracts prepared as described for the ERK activity assay using the incorporation of 32 
Signaling Events in the Mitogenic Interaction Between Oleic Acid and Ang II
Ang II, acting via its G protein-coupled AT 1 receptor, activates phospholipase C, which hydrolyzes phosphatidylinositol to diacylglycerol and inositol trisphosphate. The diacylglycerol and elevated intracellular Ca 2ϩ activate PKC. Oleic acid increases predominantly cytosolic Ca 2ϩ -independent PKC activity. 8, 9, 12 PKC can activate ERK by effects at multiple points that converge at MEK. Therefore, we focused on the AT 1 receptor, PKC, MEK, and ERK in an attempt to explain the mitogenic interactions between Ang II and oleic acid.
Losartan, an AT 1 -receptor antagonist, 32 blocked the capacity of Ang II to synergistically enhance thymidine uptake in response to oleic acid, whereas PD 123319, an AT 2 -receptor antagonist, did not (Fig 2) . These data suggest that the capacity of Ang II to augment the mitogenic response to oleic acid is mediated via the AT 1 receptor, as noted previously. 20, 33 The findings do not implicate a growth-inhibitory role for AT 2 receptors in these rat aortic VSMCs. 20 PKC inhibition and depletion eliminated the synergistic mitogenic effect of the oleic acid-Ang II combination (Fig 1) . The effects of PKC inhibition and depletion on thymidine incorporation did not reflect nonspecific toxicity, since basal thymidine incorporation and the increase in response to 10% FBS were unaffected. 12 These data confirm that the mitogenic response to oleic acid is PKC dependent 12 and indicate that PKC is also required for the synergistic interaction between oleic acid and Ang II.
We previously reported that rat aortic VSMCs contain the ␣, , , and PKC isoforms. 12 Although and do not have a phorbol ester binding site, these two isoforms were downregulated by PMA after 24 hours. Activation of PKC, which had been partially purified from rat VSMCs, in response to oleic acid was almost entirely Ca 2ϩ independent. 12 This is consistent with previous reports indicating that oleic acid more potently and completely activates the Ca 2ϩ -independent and atypical PKC isoforms. 8, 9 PKC has been shown to activate ERK and has been associated with mitogenesis in various cell lines. 34 In contrast, PKC ␣, a Ca 2ϩ -dependent isoform, is less potently stimulated by oleic acid 9 and has been associated with differentiation rather than proliferation in VSMCs. 35 The novel and/or atypical PKC isoforms may explain the mitogenic response to oleic acid and the synergistic interaction with Ang II.
MEK inhibition with PD 98059 essentially blocked ERK activation in response to oleic acid and Ang II singly and combined (Fig 3) . PD 98059 and the antisense ODN prevented the significant rise of thymidine incorporation in response to oleic acid alone and the synergistic interaction with Ang II. However, PD 98059 did not significantly reduce thymidine incorporation in response to serum, which indicates that the cells were still capable of synthesizing DNA. The data also suggest that activation of MEK and ERK are important in the mitogenic response to oleic acid and the synergistic interaction with Ang II. Nevertheless, the findings could still reflect a nonspecific or toxic effect of PD 98059 on cell signaling that affected the response to oleic acid and Ang II more than to serum.
To address this concern, experiments were conducted using antisense ODNs to ERK-1 and ERK-2. The antisense ODNs reduced ERK protein expression by 83% and ERK activation in response to oleic acid by 75% (Fig 4) . Antisense also blocked the significant increase of thymidine incorporation to oleic acid alone and the synergistic interaction with Ang II. In contrast to PD 98059, antisense more effectively limited serum-induced thymidine incorporation. Collectively, these observations indicate that MEK and ERK activation are essential, although not necessarily sufficient, in mediating the mitogenic response to oleic acid and the synergistic interaction with Ang II. Moreover, serum but not oleic acid or Ang II induced activation of p38 and JNK (Fig 6) . 36 -39 These data , and serum on activation of p38 and JNK. Quiescent rat aortic VSMCs were exposed to oleic acid, Ang II alone and together, and 10% FBS for 30 minutes or UV irradiation (40 seconds) followed by 30 minutes of incubation. Cells were washed, harvested, and subjected to SDS-polyacrylamide gel electrophoresis and immunoblotted for p38, phospho-p38, JNK, and phospho-JNK. Representative immunoblots are shown.
suggest that serum can induce significant cell growth despite marked limitation of MEK and ERK activation. This response may be mediated in part via other members of the mitogenactivated protein kinase family, eg, p38 and JNK. 36 -39 Oleic acid can potently stimulate nuclear phospholipase D. However, the nuclear ADP-ribosylation factor-dependent phospholipase D activity is associated with cell proliferation, 40, 41 while oleate-dependent phospholipase D activitity is not.
Limitations
While the synergistic mitogenic effect of oleic acid and Ang II is PKC-, MEK-, and ERK-dependent, the data do not establish that activation of ERK alone is sufficient to explain this synergy. Our studies have not defined the important nuclear signaling events. In other studies, the effects of Ang II on VSMC proliferation were heterogeneous 31, 42, 43 and coincided inversely with changes in transforming growth factor-␤1. [42] [43] [44] Quantifying the effects of oleic acid on transforming growth factor-␤1 responses to Ang II in future studies might prove instructive.
Summary
Subjects with the risk factor cluster have elevated fatty acids and a more active renin-angiotensin system. Angiotensin, acting on the AT 1 receptor, synergistically augments the mitogenic response to oleic acid. Activations of PKC, MEK, and ERKs are necessary steps in the synergistic mitogenic response to oleic acid and Ang II. A synergistic mitogenic interaction between oleic acid and Ang II may accelerate vascular disease among subjects with the cardiovascular risk factor cluster.
